Shu‐Ying Chang

Evaluation of Six Proton Pump Inhibitors As Inhibitors of Various Human Cytochromes P450: Focus on Cytochrome P450 2C19

Tatyana Zvyaga, Shu‐Ying Chang, Cliff Chen et al. · Drug Metabolism and Disposition · 2012 · 123 citations

Medicine, Pharmacokinetics, Pharmacology +16

The role of adipose protein derived hydrogels in adipogenesis

Shiri Uriel, Jung‐Ju Huang, Monica L. Moya et al. · Biomaterials · 2008 · 100 citations

Engineering, Biochemistry, Bioengineering +12

Pharmacokinetics of the Dipeptidyl Peptidase 4 Inhibitor Saxagliptin in Rats, Dogs, and Monkeys and Clinical Projections

Aberra Fura, Ashish K. Khanna, Viral Vyas et al. · Drug Metabolism and Disposition · 2009 · 99 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Confirmation That Cytochrome P450 2C8 (CYP2C8) Plays a Minor Role in (S)-(+)- and (R)-(-)-Ibuprofen Hydroxylation in Vitro

Shu‐Ying Chang, Wenying Li, Sarah C. Traeger et al. · Drug Metabolism and Disposition · 2008 · 59 citations

Medicine, Pharmacokinetics, Pharmacology +15

High-performance liquid chromatographic assay for the quantitation of irbesartan (SR 47436/BMS-186295) in human plasma and urine

Shu‐Ying Chang, Daisy B. Whigan, Nimish N. Vachharajani et al. · Journal of Chromatography B Biomedical Sciences and Applications · 1997 · 48 citations

Pharmacy, Pharmacokinetics, Pharmacology +10